LI Shanshan  

  • Graduate Supervisor, Associate Chief Physician
  • Department: Osteoporosis and Bone Diseases
  • Research Area: Endocrinology and Metabolism
  • Research Interests: Clinical and Molecular Mechanisms of Metabolic Bone Diseases
  • Contact: lissane0508@126.com
  • MD from Shanghai Jiao Tong University School of Medicine, 2018
  1. Li S#, Shao R, Li S, Zhao J, Deng Q, Li P, Wei Z, Xu S, Chen L, Li B, Zou W, Zhang Z. A monoallelic variant in CCN2 causes an autosomal dominant spondyloepimetaphyseal dysplasia with low bone mass. Bone Res. 2024, 12(1):60.
  2. Li S#, Lyu S, Fu W, Hu Y, Yue H, Chen L, Zhang Z. Clinical and genetic profiles of 985 Chinese families with skeletal dysplasia.  Chin Med J (Engl).  2023, 136(12):1485-1487.
  3. Xu Y, Zhang Z, Yue H, Li S#, Zhang Z.  Monoallelic mutations in SLCO2A1 cause autosomal dominant primary hypertrophic osteoarthropathy. J Bone Miner Res. 2021, 36(8):1459-1468.
  4. Lv S, Zhao J, Xi L, Lin X, Wang C, Yue H, Gu J, Hu W, Fu W, Wei Z, Zhang H, Hu Y, Li S#, Zhang Z.  Genetics Evaluation of Targeted Exome Sequencing in 223 Chinese Probands With Genetic Skeletal Dysplasias.  Front Cell Dev Biol.  2021, 9:715042.
  5. Li SS#, He JW, Fu WZ, Liu YJ, Hu YQ, Zhang ZL. Clinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention. 2017, 32(8):1659-1666.
  • 01/01/2020-12/31/2022
    National Natural Science Foundation of China, ¥200, 000, 81900807
    Pathogenic Mechanism of Familial Spondylometaphyseal Dysplasia Caused by Mutations in the Novel Disease Gene CTGF
    Role: Principal Investigator
  • 01/01/2024-12/31/2027
    National Natural Science Foundation of China, ¥650, 000, 82370888
    Role and Mechanism of Osteoblast Lineage Dysfunction in the Pathogenesis of X-linked Dominant Hypophosphatemic Rickets/Osteomalacia
    Role: Principal Investigator